ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ORX Orefinders Resources Inc

0.035
0.00 (0.00%)
10 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Orefinders Resources Inc TSXV:ORX TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.035 0.035 0.04 0 00:00:00

Orexo to Webcast Live at VirtualInvestorConferences.com December 15th  

14/12/2022 2:29pm

GlobeNewswire Inc.


Orefinders Resources (TSXV:ORX)
Historical Stock Chart


From Jan 2022 to Jan 2025

Click Here for more Orefinders Resources Charts.

Orexo (STO:ORX) (OTCQX:ORXOY), which develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of substance use disorders and mental health, today announced that Nikolaj Sørensen, President and CEO, will present live at VirtualInvestorConferences.com on December 15th, 2022.

DATE: December 15th, 2022TIME: 9.30 AM ETLINK: https://bit.ly/3Ub0iE3

The company will be available for 1x1 meetings upon request.

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

About OrexoOrexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of substance use disorders and mental health. The products are commercialized by Orexo in the US or via partners worldwide. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercializes its lead product ZUBSOLV® for treatment of opioid use disorder. Total net sales for 2021 amounted to SEK 565 million and the number of employees was 121. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. The company is headquartered in Uppsala, Sweden, where research and development activities are performed.

For more information about Orexo please visit www.orexo.com. You can also follow Orexo on Twitter, @orexoabpubl, LinkedIn, and YouTube.

About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access.  Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

CONTACTS:Orexo AB Publ.Lena WangeIR & Communications Director+46 18 780 8800lena.wange@orexo.com 

Virtual Investor ConferencesJohn M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group (212) 220-2221johnv@otcmarkets.com 

1 Year Orefinders Resources Chart

1 Year Orefinders Resources Chart

1 Month Orefinders Resources Chart

1 Month Orefinders Resources Chart

Your Recent History